You are here

Article Text

Article menu
Download PDFPDF
Letter
Mitomycin C in sebaceous gland carcinoma with pagetoid spread
  1. K Tumuluri,
  2. G Kourt,
  3. P Martin
  1. Department of Oculoplastic and Orbital Surgery, Sydney Eye Hospital, Sydney, Australia
  1. Correspondence to: Dr Georgina Kourt Eye Associates, 149 Macquarie Street, Sydney 2000, Australia; ginaharrozemail.com.au

https://doi.org/10.1136/bjo.2003.034215

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Sebaceous gland carcinoma is a rare eyelid tumour comprising less than 1% of all eyelid malignancies.1 It commonly arises from the meibomian glands of the tarsus, but may also arise from the glands of Zeis or from the sebaceous glands of caruncle.2 It can present in a nodular or diffuse infiltrative form. The latter form with intraepithelial (pagetoid) invasion has poor prognosis as a result of delay in diagnosis as well as more extensive involvement of ocular tissues. Topical application of mitomycin C, a non-cell cycle specific alkylating agent, has been advocated for pagetoid spread of sebaceous gland carcinoma.3 We report the use of mitomycin C as adjuvant therapy in a patient with completely excised sebaceous gland carcinoma and pagetoid …

    View Full Text